Patrick McGrady

Activating mutations in ALK provide a therapeutic target in neuroblastoma

Rani E. George, Takaomi Sanda, Megan Hanna et al. · Nature · 2008 · 892 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma

Edward F. Attiyeh, Wendy B. London, Yaël P. Mossé et al. · New England Journal of Medicine · 2005 · 573 citations · Full text

Medicine, Genetics, Oncology +15

ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma

Scott C. Bresler, Daniel A. Weiser, Peter J. Huwe et al. · Cancer Cell · 2014 · 387 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Copy number variation at 1q21.1 associated with neuroblastoma

Sharon J. Diskin, Cuiping Hou, Joseph Glessner et al. · Nature · 2009 · 358 citations

Life Sciences, Genetics, Molecular Genetics +12

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

Kai Wang, Sharon J. Diskin, Haitao Zhang et al. · Nature · 2010 · 314 citations · Full text

Medicine, Genetics, Oncology +13